DT Cloud Acquisition Corp

DYCQ

New York, New York, May 20, 2025 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud”, the “SPAC” or the “Company”), a publicly-traded special purpose acquisition company, today announced that its Extraordinary General Meeting (“EGM”), previously scheduled at 10:00 a.m. Eastern Time on May 21, 2025, has been postponed to 10:00 a.m. Eastern Time on May 23, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on May 21, 2025.

New York, New York, April 17, 2025 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud” or the “SPAC”), a publicly-traded special purpose acquisition company, today announced that its Extraordinary General Meeting (“EGM”), previously scheduled at 10:00 a.m. Eastern Time on April 18, 2025, has been postponed to 10:00 a.m. Eastern Time on April 23, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on April 21, 2025.

NEW YORK , Feb. 28, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating DT Cloud Acquisition Corporation (Nasdaq: DYCQ ), relating to the proposed merger with Maius Pharmaceutical Co., Ltd.

New York, New York, Feb. 20, 2025 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud” or the “SPAC”), a publicly-traded special purpose acquisition company, today announced that it has cancelled the extraordinary general meeting of its shareholders that was previously scheduled for 10:00 a.m. Eastern Time on February 21, 2025 (the “EGM”), and has withdrawn from consideration by the shareholders the proposals set forth in the Company's definitive proxy statement for the EGM filed with the U.S. Securities and Exchange Commission (the “SEC”) on January 27, 2025 and amended and supplemented on February 4, 14 and 19, 2025.

New York, New York, Feb. 19, 2025 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud” or the “SPAC”), a publicly-traded special purpose acquisition company, today announced that its Extraordinary General Meeting (“EGM”), previously scheduled at 10:00 a.m. Eastern Time on February 18, 2025, has been postponed to 10:00 a.m. Eastern Time on February 21, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on February 19, 2025.

New York, New York, Oct. 23, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud” or the “SPAC”), a publicly-traded special purpose acquisition company, and Maius Pharmaceutical Co., Ltd. (“Maius” or the “Company”), a biopharmaceutical R&D company, announced that they had entered into a definitive business combination agreement (the “Business Combination Agreement”) for the merger transactions (the “Business Combination,” and the transactions in connection with the Business Combination collectively, the “Transaction”). As contemplated in the Business Combination Agreement, upon closing of the Transaction, Maius will become a wholly-owned subsidiary of Maius Pharmaceutical Group Co., Ltd., a newly formed holding company (“Pubco”), the securities of which will be listed on The Nasdaq Stock Market LLC (“Nasdaq”).

New York, New York, Sept. 03, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (the “Company”) today announced that it has entered into a non-binding letter of intent (“LOI”) for a business combination with Shanghai Maius Pharmaceutical Technology Co., LTD (“Shanghai Maius”). Founded in 2015, Shanghai Maius is a biopharmaceutical R&D company focusing on innovative formulations and targeted small-molecule chemical drugs. Its core products include small-molecule chemical drugs and peptide drugs.